Stem Cell Therapy Market: Trends, Applications, Industry Competitive Analysis, Growth,Forecast: 2019 to 2029 – The Scarlet

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Stem Cell Therapy market.

Trusted Business Insights presents an updated and Latest Study on Stem Cell Therapy Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Stem Cell Therapy market during the forecast period (2019-2029). It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Abstract, Snapshot, Market Analysis & Market Definition: Stem Cell Therapy Market Industry / Sector Trends

Stem Cell Therapy Market size was valued at USD 7.8 billion in 2018 and is expected to witness 10.2% CAGR from 2019 to 2025.

U.S. Stem Cell Therapy Market Size, By Type, 2018 & 2025 (USD Million)

Rising prevalence of chronic diseases will positively impact the stem cell therapy market growth. Cardiovascular diseases, neurological disorders and other chronic conditions have resulted in high mortality over past few years. Conventional therapeutic methods and treatments are currently replaced due to lack of efficiency and efficacy. Recently developed stem cell therapies are capable of replacing defective cells to treat diseases that has reduced morbidity drastically. Therefore, people have now started relying on stem cell therapy that has long term positive effects.

Advancements in stem cell therapy in developed regions such as North America and Europe have boosted the industry growth. Since past few years, there have been several researches carried out for stem cell therapy. Currently developed stem cell therapies have shown positive outcomes in treatment of leukemia. Similarly, due to advancements in regenerative medicine, several other chronic conditions such as muscular dystrophy and cardiovascular diseases also have been cured. Aforementioned factors have surged the industry growth. However, high cost of allogenic stem cell therapy may hamper the industry growth to some extent.

Market Segmentation, Outlook & Regional Insights: Stem Cell Therapy Market

Stem Cell Therapy Market, By Type

Allogenic stem cell therapy segment held around 39% revenue share in 2018 and it is anticipated to grow substantially during analysis timeframe. Allogenic stem cell is available as off the shelf therapy and it is easily scalable that helps in providing treatment without delay. Moreover, the procedure includes culturing donor-derived immunocompetent cells that are highly effective in treatment of several diseases. Stem cells obtained in allogenic therapy are free of contaminating tumor cells. This reduces risk for disease recurrence that will surge its demand thereby, stimulating segment growth.

Autologous stem cell therapy segment is estimated to witness 10.1% growth over the forthcoming years. People usually prefer autologous stem cell therapy as it has minimum risk of immunological rejection. However, on introduction of allogenic stem cell therapy, demand for autologous stem cell therapy has declined as it is difficult to scale up. However, there are concerns regarding risk of cross contamination during large scale manufacturing of autologous stem cell lines that will impede segmental growth to some extent.

Stem Cell Therapy Market, By Application

Neurology segment was valued around USD 1.6 billion in 2018 and it is estimated that it will witness significant growth over the forthcoming years. Stem cells are used to replenish the disrupted neurological cells that helps in quick patient recovery. Pluripotent stem cells provide replacement for cells and tissues to treat Alzheimers, Parkinsons disease, cerebral palsy, amyotrophic lateral sclerosis and other neurodegenerative diseases. Thus, pivotal role of stem cells in treating life threatening neurological condition will escalate segment growth.

Cardiovascular segment will witness 10% growth over the analysis timeframe. Considerable segmental growth can be attributed to development in stem cell therapies that have enhanced recovery pace in patients suffering from cardiovascular diseases. Recently developed allogenic stem cell therapies are efficient and easily available that have reduced the mortality rates in cardiovascular patients. Above mentioned factors will propel cardiovascular segment growth in near future.

Germany Stem Cell Therapy Market Size, By Application, 2018 (USD Million)

Stem Cell Therapy Market, By End-users

Hospitals segment held over 56% revenue share in 2018 and it is anticipated to grow significantly in near future. Rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately. Associations with research and academic institutes further helps hospitals to upgrade its stem cell treatment offerings that positively impacts the segmental growth.

Clinics segment is expected to grow at around 10% during the forecast timeframe. Clinics specializing in providing stem cell therapies are well-equipped with advanced medical devices and superior quality reagents required for imparting stem cell therapies. However, as clinics offer specialized stem cell therapies, their treatment cost is much higher as compared to hospitals that may reduce its preference.

Stem Cell Therapy Market, By Region

North America stem cell therapy market held around 41.5% revenue share in 2018 and it is estimated to grow substantially in near future. Increasing adoption of novel stem cell therapies will prove beneficial for regional market growth. Moreover, favourable government initiatives have positive impact on the regional market growth. For instance, government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies enabling development in stem cell therapy. Above mentioned factors are expected to drive the North America market growth.

Asia Pacific stem cell therapy market is anticipated to witness 10.8% growth in near future owing to increasing awareness amongst people pertaining to benefits of advanced stem cell therapies. Additionally, favourable initiatives undertaken by several organizations will promote industry players to come up with innovative solutions. For instance, according to Pharma Focus Asia, members of Asia-Pacific Economic Cooperation collaborated with Life Sciences Innovation Forum to involve professionals having expertise in stem cell therapies from academia and research centers to promote developments in stem cell research. Thus, growing initiatives by organizations ensuring availability of new stem cell therapies will foster regional market growth.

Latin America Stem Cell Therapy Market Size, By Country, 2025 (USD Million)

Key Players, Recent Developments & Sector Viewpoints: Stem Cell Therapy Market

Key industry players in stem cell therapy market include Astellas Pharma Inc, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast Ltd, ReNeuron Group and Takeda Pharmaceuticals. Chief industry players implement several initiatives such as mergers and acquisitions to sustain market competition. Also, receiving approvals for stem cell therapy products from regulatory authorities fosters companys growth. For instance, in March 2018, European Commission approved Takedas Alofisel that is off-the-shelf stem cell therapy. Product approval will help company to gain competitive advantage and capture market share.

Stem Cell Therapy Industry Viewpoint

Stem cells industry can be traced back to 1950s. In 1959 first animals were made by in-vitro fertilization by preserving the stem cells. Till 2000, research was being carried out on stem cells to study its therapeutic effect. In 2000, fund allocations were made to research on cells derived from aborted human foetuses. In the same year, scientists derived human embryonic stem cells from the inner cell mass of blastocytes. Later, in 2010, clinical trials for human embryonic stem cell-based therapy were initiated. As technology progressed, stem cell therapy for treating cancer were developed. However, due to ethical issues, the use of stem cells for curing diseases witnessed slow growth for few years. But as the regulatory scenario changed, people started preferring stem cell therapies due to its better efficacy. Stem cell therapy is in developing stage and has numerous growth opportunities in developing economies with high prevalence of chronic diseases.

Key Insights Covered: Exhaustive Stem Cell Therapy Market 1. Market size (sales, revenue and growth rate) of Stem Cell Therapy industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Stem Cell Therapy industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Stem Cell Therapy industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Stem Cell Therapy industry.

Research Methodology: Stem Cell Therapy Market

Looking for more? Check out our repository for all available reports on Stem Cell Therapy in related sectors.

Quick Read Table of Contents of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Trusted Business Insights Shelly Arnold Media & Marketing Executive Email Me For Any Clarifications Connect on LinkedIn Click to follow Trusted Business Insights LinkedIn for Market Data and Updates. US: +1 646 568 9797 UK: +44 330 808 0580

The rest is here:
Stem Cell Therapy Market: Trends, Applications, Industry Competitive Analysis, Growth,Forecast: 2019 to 2029 - The Scarlet

Global Canine Stem Cell Therapy Market 2027 Register a Xx% CAGR In Terms Of Revenue: VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana…

Canine Stem Cell Therapy Market

DataIntelo, 12-08-2020: The research report on the Canine Stem Cell Therapy Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.

Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied systematically, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report.

Get a PDF Copy of the Sample Report for Free @ https://dataintelo.com/request-sample/?reportId=82309

The Major Manufacturers Covered in this Report: VETSTEM BIOPHARMA Cell Therapy Sciences Regeneus Aratana Therapeutics Medivet Biologics Okyanos Vetbiologics VetMatrix Magellan Stem Cells ANIMAL CELL THERAPIES Stemcellvet

The Research Study Focuses on:

By Types: Allogeneic Stem Cells Autologous Stem cells

By Applications: Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

By Regions:

To get this report at incredible Discounts, visit @ https://dataintelo.com/ask-for-discount/?reportId=82309

The Canine Stem Cell Therapy Market Report Consists of the Following Points:

Make an Inquiry of the Canine Stem Cell Therapy Market Report @ https://dataintelo.com/enquiry-before-buying/?reportId=82309

In conclusion, the Canine Stem Cell Therapy Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rate, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.

About DataIntelo: DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex Mathews Address: 500 East E Street, Ontario, CA 91764, United States. Phone No: USA: +1 909 545 6473 | IND: +91-7000061386 Email: [emailprotected] Website: https://dataintelo.com

See the article here:
Global Canine Stem Cell Therapy Market 2027 Register a Xx% CAGR In Terms Of Revenue: VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana...

Joliet toddler with cancer missed 2nd birthday at home due to Chicago riots – The Herald-News

Owen Buell of Joliet has gone through a lot in his short toddler life.

In February, Owen was diagnosed with a neuroblastoma, a type of cancer most commonly found in children age 5 or younger.

Hes had chemotherapy, and he had the first of two stem cell transplants on July 8.

And even when Owen went to a nearby Ronald McDonald House, he returned to the hospital for three days due to an infection his central line, said his grandmother, Jackie Moore of Florida.

Owen has had a feeding tube, numerous ports, bone marrow tests, stem cell extractions, major abdominal surgery, according to The Help for Baby Owen Buell and his Family Facebook page, which Moore moderates.

So you can imagine how excited his family was to celebrate his second birthday Monday. Moore even shipped a 3-foot-tall stuffed llama to Owens home to surprise him because Owen loves llamas.

Except Owen didnt get to see the llama.

Or any of his other birthday gifts.

He wasnt there.

Owen and his parents, Brian Buell and Valerie Mitchell, were at a Ronald McDonald House in Chicago. The Ann & Robert H. Lurie Childrens Hospital of Chicago was supposed to discharge him on Monday, but that didnt happen because of the riots, Moore said.

The hospital website said some clinics might be canceled due to unrest in the city.

Moore said shes upset, not just for Owen and his parents, but also for the other families at Ronald McDonald House with children who are also fighting for their lives.

Can you imagine those kids being inside and listening to this? Moore said. They can still look out the windows and hear the sirens and hear the gunshots. Its terrifying.

Moores also worried about the food situation for the families at the Ronald McDonald House.

Meals are freshly made meals provided by caring volunteers, according to the Ronald McDonald House Charities of Chicagoland & NW Indiana website.

Moores afraid volunteers wont be able to get near the Ronald McDonald House to bring nourishing meals or restock supplies.

There might be Twinkies and Zingers and fruit chews, Moore said. But its not a meal.

When Owen is finally discharged, he will come home with a shopping bag full of medical supplies, Moore said.

In a few weeks, Owen will resume is cancer treatments in preparation for a second stem cell transplant.

The goal of the transplant is to make his bones more receptive to the chemo and possibly have him go into remission, according to the Help for Baby Owen Buell and his Family Facebook page.

In the meantime, Owens brothers, Elliott, age 7, and Bentley, age 4, decorated the house for the occasion, Moore said.

Owens gifts are waiting for him to unwrap them.

I told my daughter, Put the cake in the refrigerator, Moore said. At 2 years old, he doesnt know its his birthday. Hell be just as happy tomorrow if he can go home.

She paused.

And I hope he likes the llama Grandma got him, she said.

Donate to Owen through GoFundMe at bit.ly/2S7sPN7.

See original here:
Joliet toddler with cancer missed 2nd birthday at home due to Chicago riots - The Herald-News

Global Cell Therapy Technologies Market : Industry Analysis and Forecast (2019-2026) by Product, Technique, End Users and Region. – Good Night, Good…

Global Cell Therapy Technologies Marketwas valued US$ 12 billion in 2018 and is expected to reach US$ 35 billion by 2026, at CAGR of 12.14 %during forecast period.

The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Cell Therapy Technologies Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on market in forecast period. PORTERs analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global Cell Therapy Technologies Market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Global Cell Therapy Technologies Market: Overview

Cell therapy is a transplantation of live human cells to replace or repair damaged tissue and/or cells. With the help of new technologies, limitless imagination, and innovative products, many different types of cells may be used as part of a therapy or treatment for different types of diseases and conditions. Celltherapy technologies plays key role in the practice of medicine such as old fashioned bone marrow transplants is replaced by Hematopoietic stem cell transplantation, capacity of cells in drug discovery. Cell therapy overlap with different therapies like, gene therapy, tissue engineering, cancer vaccines, regenerative medicine, and drug delivery. Establishment of cell banking facilities and production, storage, and characterization of cells are increasing volumetric capabilities of the cell therapy market globally. Initiation of constructive guidelines for cell therapy manufacturing and proven effectiveness of products, these are primary growth stimulants of the market.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/31531

Global Cell Therapy Technologies Market: Drivers and Restraints

The growth of cell therapy technologies market is highly driven by, increasing demand for clinical trials on oncology-oriented cell-based therapy, demand for advanced cell therapy instruments is increasing, owing to its affordability and sustainability, government and private organization , investing more funds in cell-based research therapy for life-style diseases such as diabetes, decrease in prices of stem cell therapies are leading to increased tendency of buyers towards cell therapy, existing companies are collaborating with research institute in order to best fit into regulatory model for cell therapies.Moreover, Healthcare practitioners uses stem cells obtained from bone marrow or blood for treatment of patients with cancer, blood disorders, and immune-related disorders and Development in cell banking facilities and resultant expansion of production, storage, and characterization of cells, these factors will drive the market of cell therapy technologies during forecast period.

On the other hand, the high cost of cell-based research and some ethical issue & legally controversial, are expected to hamper market growth of Cell Therapy Technologies during the forecast period

AJune 2016, there were around 351 companies across the U.S. that were engaged in advertising unauthorized stem cell treatments at their clinics. Such clinics boosted the revenue in this market. in August 2017, the U.S. FDA announced increased enforcement of regulations and oversight of clinics involved in practicing unapproved stem cell therapies. This might hamper the revenue generation during the forecast period; nevertheless, it will allow safe and effective use of stem cell therapies.

Global Cell Therapy Technologies Market: Segmentation Analysis

On the basis of product, the consumables segment had largest market share in 2018 and is expected to drive the cell therapy instruments market during forecast period at XX % CAGR owing to the huge demand for consumables in cell-based experiments and cancer research and increasing number of new product launches and consumables are essential for every step of cell processing. This is further expected to drive their adoption in the market. These factors will boost the market of Cell Therapy Technologies Market in upcoming years.

On the basis of process, the cell processing had largest market share in 2018 and is expected to grow at the highest CAGR during the forecast period owing to in cell processing stage,a use of cell therapy instruments and media at highest rate, mainly in culture media processing. This is a major factor will drive the market share during forecast period.

Global Cell Therapy Technologies Market: Regional Analysis

North America to held largest market share of the cell therapy technologies in 2018 and expected to grow at highest CAGR during forecast period owing to increasing R&D programs in the pharmaceutical and biotechnology industries. North America followed by Europe, Asia Pacific and Rest of the world (Row).

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/31531

Scope of Global Cell Therapy Technologies Market

Global Cell Therapy Technologies Market, by Product

Consumables Equipment Systems & Software Global Cell Therapy Technologies Market, by Cell Type

Human Cells Animal Cells Global Cell Therapy Technologies Market, by Process Stages

Cell Processing Cell Preservation, Distribution, and Handling Process Monitoring and Quality Control Global Cell Therapy Technologies Market, by End Users

Life Science Research Companies Research Institutes Global Cell Therapy Technologies Market, by Region

North America Europe Asia Pacific Middle East & Africa South America Key players operating in the Global Cell Therapy Technologies Market

Beckman Coulter, Inc. Becton Dickinson and Company GE Healthcare Lonza Merck KGaA MiltenyiBiotec STEMCELL Technologies, Inc. Terumo BCT, Inc. Thermo Fisher Scientific, Inc. Sartorius AG

MAJOR TOC OF THE REPORT

Chapter One: Cell Therapy Technologies Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Cell Therapy Technologies Market Competition, by Players

Chapter Four: Global Cell Therapy Technologies Market Size by Regions

Chapter Five: North America Cell Therapy Technologies Revenue by Countries

Chapter Six: Europe Cell Therapy Technologies Revenue by Countries

Chapter Seven: Asia-Pacific Cell Therapy Technologies Revenue by Countries

Chapter Eight: South America Cell Therapy Technologies Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Cell Therapy Technologies by Countries

Chapter Ten: Global Cell Therapy Technologies Market Segment by Type

Chapter Eleven: Global Cell Therapy Technologies Market Segment by Application

Chapter Twelve: Global Cell Therapy Technologies Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Cell Therapy Technologies Market Report at:https://www.maximizemarketresearch.com/market-report/global-cell-therapy-technologies-market/31531/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Go here to read the rest:
Global Cell Therapy Technologies Market : Industry Analysis and Forecast (2019-2026) by Product, Technique, End Users and Region. - Good Night, Good...

Global Nerve Repair and Regeneration Market Outlook 2020: Company Profiles of Key Players Axogen, Baxter, Nevro, Nuvectra, Polyganics and Stryker -…

DUBLIN--(BUSINESS WIRE)--Aug 10, 2020--

The "Nerve Repair and Regeneration - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global Nerve Repair and Regeneration market accounted for $6.46 billion in 2018 and is expected to reach $21.68 billion by 2027 growing at a CAGR of 14.4% during the forecast period. Some of the key factors propelling the market growth are technological developments for nerve repair and regeneration and an increase in healthcare expenses by government with sympathetic policies. However, elevated prices associated with devices is a restraining factor for the growth of the market.

By product, the neurostimulation and neuromodulation devices segment is expected to grow at a significant market share during the forecast period due to mounting incidence of peripheral nerve injuries, technological development in the field. Sympathetic reimbursement policies are expected to drive the growth of this market segment in the next five years. On the basis of geography, Asia Pacific is anticipated to hold considerable market share during the forecast period due to increasing numbers of patients suffering from chronic diseases, and an increase in government initiatives for the development of healthcare services in the region.

What the report offers:

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Application Analysis

3.8 End User Analysis

3.9 Emerging Markets

3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product

5.1 Introduction

5.2 Neurostimulation and Neuromodulation Devices

5.2.1 Internal Neurostimulation Devices

5.2.1.1 Deep Brain Stimulation

5.2.1.2 Gastric Electrical Stimulation

5.2.1.3 Sacral Nerve Stimulation

5.2.1.4 Spinal Cord Stimulation

5.2.1.5 Vagus Nerve Stimulation

5.2.2 External Neurostimulation Devices

5.2.2.1 Transcranial Magnetic Stimulation

5.2.2.2 Transcutaneous Electrical Nerve Stimulation

5.3 Biomaterials

5.3.1 Nerve Wraps

5.3.2 Nerve Connectors

5.3.3 Nerve Conduits

5.3.4 Nerve Protectors

6 Global Nerve Repair and Regeneration Market, By Application

6.1 Introduction

6.2 Nerve Grafting

6.2.1 Autografts

6.2.2 Allografts

6.2.3 Xenografts

6.3 Neurostimulation and Neuromodulation Surgeries

6.3.1 Internal Neurostimulation and Neuromodulation Surgeries

6.3.2 External Neurostimulation and Neuromodulation Surgeries

6.4 Direct Nerve Repair/Neurorrhaphy

6.4.1 Epineural Repair

6.4.2 Group Fascicular Repair

6.4.3 Perineural Repair

6.5 Stem Cell Therapy

7 Global Nerve Repair and Regeneration Market, By End User

7.1 Introduction

7.2 Ambulatory Surgery Centers

7.3 Clinics

7.4 Hospitals

8 Global Nerve Repair and Regeneration Market, By Geography

8.1 Introduction

8.2 North America

8.3 Europe

8.4 Asia Pacific

8.5 South America

8.6 Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures

9.2 Acquisitions & Mergers

9.3 New Product Launch

9.4 Expansions

9.5 Other Key Strategies

10 Company Profiling

10.1 Abbott Laboratories

10.2 Axogen

10.3 Baxter

10.4 Boston Scientific

10.5 Integra Lifesciences

10.6 Livanova

10.7 Medtronic

10.8 Neuropace

10.9 Nevro

10.10 Nuvectra

10.11 Orthomed

10.12 Polyganics

10.13 Stryker

For more information about this report visit https://www.researchandmarkets.com/r/f3k098

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200810005339/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH MEDICAL DEVICES

Excerpt from:
Global Nerve Repair and Regeneration Market Outlook 2020: Company Profiles of Key Players Axogen, Baxter, Nevro, Nuvectra, Polyganics and Stryker -...

Impact of COVID-19 Outbreak on Canine Stem Cell Therapy Market Expected to Secure Notable Revenue Share During 2020-2026 – Research Newspaper

This Canine Stem Cell Therapy Market report includes worldwide topmost prime manufactures like (VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, Stemcellvet) in terms of company basic information, Product Category, Sales (Volume), Revenue (Million USD), Price, Gross Margin (%), Price, Cost, Growth Rate, Import, Export, Market Share and Technological Developments. Canine Stem Cell Therapy Market report provide the COVID19 Outbreak Impact analysis of key factors influencing the growth of the Canine Stem Cell Therapy market Size (Production, Value and Consumption). In the end, the Canine Stem Cell Therapy industry report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Canine Stem Cell Therapy[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2081893

Canine Stem Cell Therapy Market Report Offers Comprehensive Assessment Of 1) Executive Summary, 2) Canine Stem Cell Therapy Market Overview, 3) Key Market Trends, 4) Key Success Factors, 5) Market Demand/Consumption (Value or Size in US$ Mn) Analysis, 6) Canine Stem Cell Therapy Market Background, 7) Canine Stem Cell Therapy industry Analysis & Forecast 20202026 by Type, Application and Region, 8) Canine Stem Cell Therapy Market Structure Analysis, 9) Competition Landscape, 10) Company Share and Company Profiles, 11) Assumptions and Acronyms and, 12) Research Methodology etc.

Scope of Canine Stem Cell Therapy Market:The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Allogeneic Stem Cells Autologous Stem cells

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2081893

The report offers in-depth assessment of the growth and other aspects of the Canine Stem Cell Therapy market in important countries (regions), including:

The Following Points Are Important In Performing A Competitive Assessment of Canine Stem Cell Therapy Market:

What will make the customer buy from this operation instead of the competition?

Comparison between the products/services to the competitors products/services of Canine Stem Cell Therapy market (Features, Service, Quality, Price, Distribution, And Brand).

List the companies involved in the production of these products/services.

Describe the Canine Stem Cell Therapy market concentration (Such As Large Number of Small Players or Small Number of Large Players).

Detail the Canine Stem Cell Therapy market prevailing competitive intensity (Fierce Competition or Live and Let-Live).

Describe the competitors facile Canine Stem Cell Therapy market entry (Can the Easy Entry of Competitors Drive down Prices in the Market?)

Describe the clients competitive strategies against competitors and their products of Canine Stem Cell Therapy market(Low Cost, Niche Market, Product Differentiation, Etc.).

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Read the rest here:
Impact of COVID-19 Outbreak on Canine Stem Cell Therapy Market Expected to Secure Notable Revenue Share During 2020-2026 - Research Newspaper

Flow Cytometry Market 2020 | Research Objectives and Methodology, Growth Analysis, Top Manufacturers Sales, and Cost Structures Forecast 2024 – Owned

Agilent Technologies

Report Highlights:

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999638

Key Market Trends:

Stem Cell Therapy is Expected to Hold the Largest Market Share, by Application

The stem cell therapy segment is believed to have the largest market size and is expected to witness a CAGR of 8.4% during the forecast period.

The key reasons for the large market share include the extensive use of flow cytometry for effective diagnosis and early detection of numerous diseases that have helped the market to gain immense shares. There has been a growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and the evolution of tandem flow cytometry technologies that are expected to offer growth opportunities for the players operating in the flow cytometry market during the forecast period.

Though flow cytometry has also found many applications in several stages of drug discovery, its routine widespread use for high throughput drug screening has been limited. This is unlike analogous technology, automated high content imaging (HCI), which, in terms of drug screening, is an established technology that is common in screening laboratories.

North America Dominates the Market and is Expected to Continue its Lead over the Forecast Period

North America holds a major share of the flow cytometry market and is projected to continue over the next few years. An increasing prevalence of diseases and the rising contribution from the US market are expected to help the market grow. In addition, there has also been a rise in the expansion of novel products that are anticipated to offer new growth opportunities in the coming years.

The Report Covers:

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/13999638

Detailed TOC of Flow Cytometry Market Report 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Use of Flow Cytometry in Stem Cell Research 4.2.2 Emergence and Commercial Applications of New Technologies in the Field of Flow Cytometry 4.2.3 Increasing Applications of Flow Cytometry in Clinical Research 4.3 Market Restraints 4.3.1 Lack of Awareness about the Potential Benefits of Flow Cytometry Techniques 4.3.2 Expensive Equipment 4.4 Industry Attractiveness Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 Product Type 5.1.1 Instrument 5.1.2 Fluorophore 5.1.3 Kit and Reagent 5.1.4 Software 5.1.5 Other Product Types 5.2 Technology 5.2.1 Cell-based Flow Cytometry 5.2.2 Bead-based Flow Cytometry 5.3 Application 5.3.1 Oncology 5.3.2 Drug Discovery 5.3.3 Disease Diagnosis 5.3.4 Stem Cell Therapy 5.3.5 Organ Transplantation 5.3.6 Hematology 5.3.7 Other Applications 5.4 By End User 5.4.1 Hospitals and Clinics 5.4.2 Academia and Research Institutes 5.4.3 Pharmaceutical and Biotechnology Companies 5.4.4 Other End Users 5.5 Geography 5.5.1 North America 5.5.1.1 US 5.5.1.2 Canada 5.5.1.3 Mexico 5.5.2 Europe 5.5.2.1 Germany 5.5.2.2 UK 5.5.2.3 France 5.5.2.4 Italy 5.5.2.5 Spain 5.5.2.6 Rest of Europe 5.5.3 Asia-Pacific 5.5.3.1 China 5.5.3.2 Japan 5.5.3.3 India 5.5.3.4 Australia 5.5.3.5 South Korea 5.5.3.6 Rest of Asia-Pacific 5.5.4 Middle East & Africa 5.5.4.1 GCC 5.5.4.2 South Africa 5.5.4.3 Rest of Middle East & Africa 5.5.5 South America 5.5.5.1 Brazil 5.5.5.2 Argentina 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Becton, Dickinson and Company 6.1.2 Beckman Coulter 6.1.3 EMD Millipore (Merck KGaA) 6.1.4 Bio-Rad Laboratories 6.1.5 Luminex Corporation 6.1.6 Life Technologies 6.1.7 Miltenyi Biotech 6.1.8 Sysmex Partec GmbH 6.1.9 Agilent Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Foil Winding Machines Market 2020 Industry Outlook by Business Share, Industry Price Trend, Size Estimation, Latest Research Report by Business Analysis and Forecast Research till 2025

Metallized BOPP Film Market Size of Key Players Research by Global Business Opportunities, Industry Growth Rate, Demand Status, Regional Analysis, Forecast to 2020-2024

Military Aerial Refueling Tanker Market Size with Current Industry Scenario, Latest Opportunity, Top Key Players, Industry Share with Growth Analysis Forecast to 2020-2024 with COVID-19 Analysis

Cloud Analytics Market Development Analysis Contributing Top Vendor Landscape 2020 Global Share and Size, Future Plans by Top Key Players and Economic Growth 2025 with COVID-19 Impact

Home Dressing Table Market Share Value 2020 Industry Top Players, Trends, Global Growth Rate by Size Expansion Strategies by 2026 Report Includes COVID-19 Analysis

Walnut Milk Market 2020 Global Business Growth, Industry Size, Share, Revenue, Trends, Global Market Demand Penetration and Forecast to 2025

Read more:
Flow Cytometry Market 2020 | Research Objectives and Methodology, Growth Analysis, Top Manufacturers Sales, and Cost Structures Forecast 2024 - Owned

Unproven stem cell therapies, and now, strong words from the FDA – BioNews

27 July 2020

There has been general concern around the reports of untested stem celltreatments being sold before they have been proven safe and effective. A recent publication by the US' Food and Drug Administration (FDA)represents an informal forewarning to the rogue doctors operating outside of the regulatory regime that they may not get extra time to comply with the agency's strict regulation of regenerative medicine products.

This piece, which uses strong language, underscores the regulatory agency's firm commitment to evidence-based regenerative products.

In 2017, the FDA articulated the regulatory criteria for product marketing through the publication of four guidance documents. These documents build upon the agency's existing risk-based, flexible regulatory regime. They enable stakeholders to understand better how the regulatory criteria apply to their products by clarifying complex technical definitions such as 'minimal manipulation' and 'homologous use'.

This coming November will mark the end of the three years of enforcement discretion announced by the FDA when it first set up this stringent regulatory framework. This approach allows product manufacturers sufficient time to engage with the agency to comply with the requirements, eg, to determine whether they must submit a marketing authorisation application to the FDA for their approval. In the recent piece, there is no indication of a deadline extension.

The authors, Dr Stephen Hahn (FDA's new commissioner) and Dr Peter Marks (Centre for Biologics and Evaluation and Research (CBER) director), state that '... these products, whether autologous (taken from the patient) or allogeneic (donated), are not inherently safe and may be associated with serious adverse consequences'. This piece places the unproven stem cell therapy issue in the context of the COVID-19 pandemic, during which some clinics selling unproven stem cell therapies have exploited the fears of the vulnerable public.

It also indicates that 'the increasing number of adverse events being reported following the widespread use of unapproved regenerative medicine therapies at hundreds of clinics across the country make it necessary for the FDA to act to prevent harm to individuals receiving them.' This point is indeed commendable as it represents the increasingly proactive measures being taken by the FDA in taking enforcement action.

The authors request engagement from patients, their family and friends as well as clinicians 'to help to ensure that instead of remaining unintentionally or intentionally hidden, potentially harmful unapproved regenerative medicine therapies are identified and then removed from the market.' Some clinics may attempt to avoid being on the FDA's radar, however, there is reliable research that should help inform the FDA about the emergence of hundreds, if not a thousand such centres in the US.

Crucially, the article provides some useful and practical guidelines for patients to refer to when evaluating whether a cellular product is offered in compliance with the FDA regulations. For patients contemplating therapies involving a cellular product, the authors recommend the following steps as appropriate practices: first, they need to verify whether the product is FDA-approved or whether an investigational new drug (IND) application for the product is currently on file with the FDA. Next, the patient must provide written informed consent to participate in a clinical trial under that IND and compliance with institutional review board (IRB) requirements.

Moreover, the patient must not be charged for either the unapproved product or for participation in the clinical trial unless there is evidence of benefit to the patient, in which case the amount charged must not exceed the actual direct costs to create the product (cost recovery). And this must be documented by a certified public accountant.

On a critical note, patients (and family, friends and clinicians) are encouraged to report adverse medical events after receiving the product and the health care provider must clearly explain the specific steps for doing so, such as filling in patient-friendly forms to report the matter. Such reports will enable the FDA to get a complete picture of the range of dubious activities.

Finally, patients enrolled in the clinical trial should receive a summary of results after the clinical trial. Transparency, it is felt, will engender trust.

Interestingly, the authors state that medical professionals, including primary care physicians and nurses, are in the best position to assist patients in identifying whether the particular regenerative medicine treatment is appropriate for them to pursue. It is doubtful whether this represents an accurate position as there may be a wide range of knowledge and awareness of stem cell interventions even among the doctors.

The article, written amid a pandemic when the FDA is occupied with other pressing matters, reiterates the agency's obligation to its fundamental mission. Collectively, this piece and the recent escalation in warnings, as well as untitled letters sent by FDA to clinics proffering unapproved stem cell treatments, may indicate that these companies may not be granted more time to comply with the requirements. The remaining months may provide some inkling into what the enforcement situation is likely to be as the FDA's enforcement discretion period finishes in November 2020.

See the original post:
Unproven stem cell therapies, and now, strong words from the FDA - BioNews

Choosing a Stem Cell Clinic: 3 Critical Questions You Must …

Cell-based therapy is one of the newest and most innovative advancements in modern medicine. Through the use of stem cells, many conditions are treated through the self-renewal and production of more cells for the treatment of diseases.

The sudden interest in stem cell therapy has created increased consumer demand. As a consequence, many stem cell clinics have sprouted worldwide that claim to offer this unique therapy.

Not all medical centers are equal however, and many operate unethically. This article is going to give you 3 critical questions you must ask before choosing a clinic. This information can empower you in making a better choice. Knowledge is essential, and when it comes to stem cell therapy the more a consumer knows, the higher the likelihood they will have in making the best decision for choosing the best stem cell clinic for their treatment.

Stem cells are somewhat analogous to the stem of a plant in the sense that everything sprouts from the stem and differentiates into different parts such as leaves, bark, flowers and seeds. The theory behind the use of stem cells in treating diseases is based on the idea that stem cells can morph into different types of cells. Their other ability is to indirectly stimulate regeneration in local tissues, as well as reduce the level of inflammation. These cells are then believed to regenerate tissues of the body and heal disease, similar to the example of the plant.

Early uses of stem cell therapy involved the use of stem cells in bone marrow transplantation, making those types of stem cells the first to be identified. Thousands of people throughout the world have been treated with stem cells for diseases like leukemia and cancers of the blood.

Since then, stem cell clinics have used the same theory to attempt to treat many other diseases with varying degrees of success. Regenerative medicine centers in Europe have been treating patients for a wide array of diseases that include:

While many people are reported to have experienced excellent results with stem cell treatment, there are also many unfortunate stories. Opportunistic fraudsters have taken advantage of some vulnerable patients with serious consequences to their health in addition to the loss of money.

Choosing a stem cell clinic requires knowledge of many concepts of cell-based therapy in order to avoid similar situations. This gives the patient or caregiver insight into the procedure and the ability to differentiate the reputable clinics from fraudulent operations that operate unethically.

The following questions are designed to educate you on the stem cell treatment process so that you are informed when asking questions while choosing a clinic:

Stem cell treatments involve an injection of a cell-based product. These are substances that are promoted to heal tissues and manage diseases, and can include items like stem cells, platelet-rich plasma and other products like extracellular matrices that are derived from the patient (autologous) or from another person (allogeneic).

An increasingly serious problem with fraudulent stem cell clinics is that they claim to offer stem cell treatment but the cells are either not alive or nonfunctional.

When asking about what types of stem cells the clinic uses, it is important to understand what types they match to each treatment.

Many clinics such as Swiss Medica in Europe offer a wide variety of cell products that include adult stem cells and stromal vascular fraction products (SVF) that contain various stem and progenitor cells, immune cells, fibroblasts and other types of cells that are promoted as being helpful in the process of regeneration, reducing inflammation and relieving pain.

There are varying degrees of qualification among the professionals offering stem cell treatments. Since this is a new field, finding quality physicians can be difficult and there is limited training at present in the university education system.

There are many types of treatment providers currently offering stem cell treatments. Therapists such as alternative healthcare practitioners or naturopaths fall under a wide umbrella of therapists offering regenerative medicine, with some entering the stem cell field in recent years. They often offer treatments at unregulated clinics performing major operations such as spinal injections for which they may not have the appropriate training. Since there is no standard training for injections, many of these therapists may not have the knowledge to handle any complications that may arise.

Some licensed medical providers, such as nurse practitioners, have undergone approximately half the training of a certified doctor. In some cases, these people are better equipped to provide treatments, however there are complex decision-making skills in critical situations that require physician-level training.

The best-case scenario in most instances would be a physician with basic injection skills and training in a practice like sports/physical medicine or orthopedic surgery. When choosing a clinic it is essential that such certified professionals with high levels of training are available to monitor the procedures and provide recommendations in the event of complications.

Another useful vetting procedure is to confirm if the doctors working in the clinic are part of any sort of regenerative medicine or tissue engineering society. Memberships in groups like this signify that the doctors are keeping their education current, and that the treatments are up to standard with the latest technology.

The site of the injection is of paramount importance to ensure a successful treatment. Some clinics inject the cells intravenously (IV) with the idea that the cells navigate to the treatment area, which is known as homing. Other clinics inject them directly into the site that has issues, to increase the local effect.

On-site injection also has varying degrees of complexity depending on the specific parts of the body part being treated. Spinal injections are some of the most complex of all due to the interaction of the nervous system with various parts of the body. For these reasons and more, specialized knowledge is required to determine the best injection site that will bring the most successful treatment.

Top questions to ask concern the efficacy of generalized IV treatments for localized conditions, such as arthritis of the knee, hip, shoulder or ankle. Additional queries should concern the complexities of the treatment site and the specific location receiving the injections.

There are many questions to ask when choosing a stem cell treatment provider. Since knowledge is power, more information leads to more questions and this is helpful in the selection process.

The most important information required by any patient or caregiver encompasses the 3 top questions discussed in this article. They include: (1) What is being injected? (2) Who is doing the injections? and (3) Where is the treatment being administered?

Armed with specialized knowledge, seekers of cell-based therapy are equipped with the information necessary to ask the right questions and assess if the doctors are qualified through their responses. This procedure will make it much easier to dismiss the fraudulent clinics and to find the best stem cell treatment provider for the highest degree of success.

READ 5 Changes You Can Make To Improve Your Overall Health

Read more here:
Choosing a Stem Cell Clinic: 3 Critical Questions You Must ...

FDA extends deadline for stem cell clinics to comply with …

Actual Covid-19 case count could be 6 to 24

Actual Covid-19 case count could be 6 to 24 times higher than official estimates, CDC study

Studies provide glimpse at efficacy of Covid-19 vaccines from

Studies provide glimpse at efficacy of Covid-19 vaccines from Oxford-AstraZeneca and CanSino

We dont actually have that answer yet: WHO clarifies

We dont actually have that answer yet: WHO clarifies comments on asymptomatic spread of Covid-19

Pharmalittle: U.S. to pay $1.95b for Pfizer-BioNTech Covid-19 vaccine;

Pharmalittle: U.S. to pay $1.95b for Pfizer-BioNTech Covid-19 vaccine; who decides who gets the first doses?

Among biotech venture capital firms, Flagship Pioneering got the

Among biotech venture capital firms, Flagship Pioneering got the best single-fund returns

Hospitals deploy AI to send patients home earlier

Hospitals deploy AI to send patients home earlier and keep them there

View post:
FDA extends deadline for stem cell clinics to comply with ...